TrialBeacon
EUClinicalTrials.govClinical trialRecruiting

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

Open the official recordBack

Official record

Identifier
NCT07035691
Recruiting locations

country

United Kingdom
Interventions studied
Not provided in the official record
Lead sponsor
Queen Mary University of London
Target enrolment
582 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Recruiting
First posted
Jun 25, 2025
Last updated on the registry
Sep 8, 2026
Age
18 Years
Sex
ALL
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Adult, lower GI 2WW and or Straight to Test (STT) referral patients with suspected lower GI cancer.
* Male and Female patients aged \>18 years.
* 2WW referral patients with no history of inflammatory bowel disease.
* Performance status (ECOG 0-2; and 3 pending clinical assessment of fitness).
* Patients with capacity to consent to the study.

Exclusion Criteria:

* Any patients referred outside of the 2WW and or STT referral pathways with suspected Lower GI cancer or those referred as an emergency with or suspected CRC.
* Age \< 18 years.
* Patients not fit for standard investigations (e.g. not fit for gastroscopy, colonoscopy or CT colonography) in the 2WW pathway.
* Patients with no capacity to consent or who declined consent for participation.
* Patients with untreated solid organ cancers.
* Patients with known inflammatory bowel disease.
* Patients with documented familial type CRC.
Indexed under
Gastric Cancer